Hormone Replacement Therapy Market 2019 Increasing Prevalence of Various Chronic Conditions | Size, Share is Set to Rise at 5.2% CAGR during 2019-2025

Global Hormone Replacement Therapy Market 2019-2025: The global hormone replacement therapy market was valued at US$ 10.58 billion in 2017 and is anticipated to grow at a CAGR of 5.2% over the forecast period (2018 – 2026).

Get a Quick Sample Brochure report at https://decisionmarketreports.com/request-sample?productID=983551

The hormone replacement therapy market is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end. Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Research study envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 5.2% in terms of value throughout the period of forecast, 2018-2025.

Hormone replacement therapy is used when human body is not able to produce enough hormones. It is used for the treatment for menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency conditions.

Rising incidences of hormonal imbalance disorders and increasing geriatric and neonatal population suffering from these diseases are expected to boost growth of the market. According to the statistics provided by the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause on a daily basis in U.S.

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/983551/hormone-replacement-therapy-market

Market Dynamics

Increasing number of people suffering from hypogonadism and rising adoption of testosterone products in various economies is expected to propel overall growth of the market. According to the data published in the European Association of Urology Journal: 2017, testosterone prescription trends in the U.S. exhibited an increase between 1.8- and 4-fold over the last two decades (1997 - 2017). Moreover, from 2000 to 2011, there was a 4.3-fold increase in testosterone testing when compared to a 3.7-fold increase in prescriptions.

Rising number of generic versions of hormone replacement therapies by various manufacturers will drive growth of the market in terms of volume and value. For instance, Teva Pharmaceutical Industries Ltd. launched the generic Axiron1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. on August 18, 2017 to treat adult males who have low or no testosterone due to certain medical conditions. This solution was supplied in a metered dose pump with an underarm applicator.

However, high cost associated with the replacement therapy and complex reimbursement scenario that causes excluding of the therapy from coverage by insurers, as it is a rare disease, hampers growth of the hormone replacement therapy market.

Key features of the study:

• This report provides in-depth analysis of the hormone replacement therapy market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global hormone replacement therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global hormone replacement therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for hormone replacement therapy market, research and consulting firms, new entrants, and financial analysts

For Better Insights help@decisionmarketreports.com

Detailed Segmentation:

• Global Hormone Replacement Therapy Market, By Therapy Type:
o Estrogen Replacement Therapy
o Human Growth Hormone (HGH) Replacement Therapy
o Thyroid Replacement Therapy
o Testosterone Replacement Therapy

• Global Hormone Replacement Therapy Market, By Route of Administration:
o Oral
o Parenteral
o Others

• Global Hormone Replacement Therapy Market, By Application:
o Hypothyroidism
o Male Hypogonadism
o Growth Hormone Deficiency
o Menopause
o Others

• Global Hormone Replacement Therapy Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

Table of Contents

1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Therapy Type
 Market Snippet, By Route of Administration
 Market Snippet, By Application
 Market Snippet, By Distribution Channel
 Market Snippet, By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Pipeline Analysis
o Epidemiology
o Regulatory Scenario
o Reimbursement Scenario
o PORTER’S Five Forces
o PEST Analysis

4. Global Hormone Replacement Therapy Market, By Therapy Type, 2016 – 2026, (US$ Million)
o Introduction
 Market Share Analysis, 2018 and 2026 (%)
 Y-o-Y Growth Analysis, 2017 – 2026
 Segment Trends
o Estrogen Replacement Therapy
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Human Growth Hormone (HGH) Replacement Therapy
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Thyroid Replacement Therapy
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Testosterone Replacement Therapy
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

5. Global Hormone Replacement Therapy Market, By Route of Administration, 2016 – 2026, (US$ Million)
o Introduction
 Market Share Analysis, 2018 and 2026 (%)
 Y-o-Y Growth Analysis, 2017 – 2026
 Segment Trends
o Oral
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Parenteral
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

...Continued

Request a In-depth Insights PDF Sample Brochure at https://decisionmarketreports.com/request-sample?productID=983551

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com

This release was published on openPR.